GILD: Gilead Sciences, Inc. - Summary | Jitta

Gilead Sciences, Inc.

NASDAQ:GILD

Price
$72.95
Loss Chance
46.2%
4.83JITTA SCORE
37.46%Over Jitta Line
Jitta Ranking
116 / 1,127
1,275 / 4,938
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (23)
Recent Business Performance (9)
Financial Strength (73)
Return to Shareholders (83)
Competitive Advantage (45)
Jitta Signs
Revenue and EarningConsistent
Return on EquityConsistently High
CapExVery Low
Interest Coverage RatioVery Good
Recent Business PerformanceEarning decline 4.13% in the last year
Key Stats
Jitta Score
Jitta Line
4.83
37.46%
1.30
140.95%
2.06
244.26%
Biotechnology
5.01
54.73%
5.02
361.06%
5.24
33.00%
COMPANY DESCRIPTION
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.